
词语导航
基本信息
词语:抗肝素
繁体:抗肝素
拼音:kàng gān sù
英语翻译
【医】 antiheparin
分词翻译
抗的英语翻译:
contend with; defy; fight; refuse; repel; resist
【医】 Adv.; contra-; ob-
肝素的英语翻译:
【化】 heparin
【医】 heparin
翻译例句
1. 你在服用抗凝药物(比如华法林,肝素)或者抗血小板聚集药物(阿司匹林或氯吡格雷)——一般情况下,在结肠镜检前应明停止服用这些药物,以防出血不止。
Are taking any blood-thinning drugs (such as warfarin or heparin) or antiplatelet medication (such as aspirin or clopidogrel)
2. 本文介绍了他们的作用机理及其临床研究,叙述了他们与肝素相比的优越之外,认为水蛭素与水蛭肽是两类非常有前途的抗栓新药。
This paper introduces their mechanism function and clinical research illustrates their advantages compated with heparin believing that both hirudin and hirulog are new promising antithrombotic agents.
3. 对于急性缺血性卒中患者,推荐不用全量抗凝,静脉输注或皮下注射低分子量肝素或类肝素(1b级)。
For patients with acute ischemic stroke, we recommend against full-dose anticoagulation with IV, sc, or LMWHs or heparinoids (Grade 1b).
4. 前言:目的:探讨肝素联合阿司匹林治疗抗磷脂综合征的疗效。
Objective: To study the therapeutic efficacy of combined heparin and aspirin for patients with antiphospholipid syndrome (APS).
5. 结论CVVH中应用无肝素抗凝技术同样高效、稳定、安全,对于高危出血患者,是保障CVVH治疗持续进行的重要措施。
Conclusion Anticoagulation without heparin is high efficient, stable and safe. It is an important measure to ensure CVVH continuously for patients with high risk of bleeding.
6. 对比研究了低抗凝活性肝素、商品肝素及以低抗凝活性肝素为原料制得的低分子肝素的免疫活性。
The immunocompetence of low molecular weight heparin(LMWH) derived from low anticoagulant activity heparin(LAAH), a by-product in commercial heparin production, was studied.
7. 观察低分子量肝素在血液透析中的抗凝效果,比较与普通肝素在护理方面的不同处理。
To observe the anticoagulation effect of low molecular weight heparin on hemodialysis and to study its related nursing aspect.
8. 低分子肝素具有较高的抗凝作用,出血副作用较一般肝素明显减少。
Low molecular heparin has the features of high anticoagulation and less side effect of bleeding as compares with the ordinary heparin.
9. 目的探讨三种不同途径给予低分子肝素抗凝进行血液透析效果。
Objective To adopt three approaches of applying low molecule heparin as anticoagulant during blood hemodialysis.
10. 方法:对比使用肝素与使用低分子肝素在血液透析中的抗凝效果,透析效果及其副作用。
Methods Compare the effect on anticoagulant therapy, hemodialysis and the side effect from the use of heparin with those from the use of Low Molecular Weight Heparins.
11. 结论:主动或被动的物理护理措施以及低分子肝素预防性抗凝可明显降低深静脉血栓形成的发生率。
Conclusion: the physical nursing of active or passive measure and preventive anticoagulant treatment by low molecular weight heparin can obviously reduce the occurrence rate of deep vein thrombosis.
12. 目的:评价抗凝药物肝素和维生素K拮抗剂的临床应用及安全性。
OBJECTIVE:To evaluate clinical usage and safe ty of anticoagulant Heparin and vitamin K antagon.
13. 结果离体肝素抗凝全血血糖下降及乳酸上升的速度与放置时间、温度成正比。
Results The speed of glucose decrease and lactic acid increase correlate with storing time and temperature when sodium heparin as anticoagulant.
14. 由于肝素修饰物制备工艺简单,安全不易出血等优点,有望开发成新的抗炎临床药物。
As modified heparin is very easy to be got and is safe for avoiding bleeding, it can be developed a new kind of anti-inflammation medicine.
15. 制备抗人肝素酶单克隆抗体,用于肝素酶的研究及临床恶性肿瘤的鉴别诊断。
To preparate the monoclonal antibody against the human heparanase for further research of clinical diagnosis of the tumour.
16. 肝素是一种高度硫酸化的蛋白聚糖,兼有很强的抗凝血活性和抗炎症活性。
Heparin, a highly sulfated proteoglycan, is known to have strong anticoagulant and anti-inflammatory activities.
17. 结论:肝素及血栓通对高血压伴缺血性脑卒中的早期治疗均有良好的抗凝及临床疗效。
Conclusion: Both heparin and XST have good anticoagulatory function and show good clinical effect in treating patients with hypertension complicated with acute ischemic cerebrovascular diseases.
18. 如果继续使用肝素锂抗凝管采集样本,可换用日本一化lap试剂。
If continuing to use heparin lithium-anticoagulant tubes, we should use LAP reagents of Daiichi Pure Chemicals.
19. 采用普通肝素抗凝。
Normal heparin was used as anticoagulant.
20. 将犬腹腔麻醉,从犬髂骨处抽取骨髓,肝素抗凝。
The dogs were anesthetized and bone marrow was aspirated and mixed with heparin.
21. 结论热缺血期间的持续通气对无肝素抗凝处理的无心跳供者的肺具有明显的保护作用。
Conclusion The ventilation during warm ischemia has markedly protective effects on rabbit lung in non heart beating donor without heparinization.
22. 目的:探讨低分子肝素钙治疗因抗磷脂抗体所致复发性流产的疗效及对孕妇血液中抗体的影响。
AIM: To explore the effect of low-molecular weight heparin calcium in treating recurrent abortion induced by anti-phospholipid antibody and the influence of the antibodies in gravida blood.
23. 目的探讨肝素治疗因抗磷脂抗体所致反复性妊娠丢失及对孕妇血液中抗体的影响。
Objective To evaluate the effect of heparin on women with recurrent pregnant loss with positive anti phospholipid antibody and its influence on these antibodies serum level.
24. 应用低分子肝素抗凝。
Low molecular weight heparin was used for anticoagulation.
25. 生物材料表面肝素固定化修饰技术是改善生物材料表面抗凝性能和生物相容性的一种有效方法。
Immobilization of heparin onto the surfaces of biomaterials is an effective approach for improving their anticoagulant properties and biocompatibility.
26. 本文结果提示,经化学修饰后的低抗凝血肝素可以用于诘抗由肿瘤细胞与血小板相互作用导致的肿瘤转移。
These results suggested that some chemically modified heparins with low anticoagulant activity may be used to inhibit the metastasis which induced by the interaction between tumor cells and platelets.
27. 无菌条件下取正常足月剖宫产胎儿的脐带血,经肝素抗凝,用淋巴细胞分离液分离脐血单个核细胞。
The specimens were obtained sterilely with preservative-free heparin, and the cord blood mononuclear cell was isolated by lymphocyte separation medium.
28. 结论联合应用替罗非班可降低抗凝肝素剂量,显著抑制血小板聚集,并呈降低降低血小板数的趋势。
Conclusions Addition to the conventional therapies with anti-platelets and anti-coagulation, tirofiban can reduce the dose of heparin, inhibit platelet aggregation and decrease the platelets number.
29. 所有的病人在大腿上应用止血带、预防性应用抗生素、低分子肝素抗凝。
A thigh tourniquet, prophylactic intravenous antibiotics, and low-molecular-weight heparin anticoagulation were used in all patients.wwW.WEnTIyI.Com
30. 低分子肝素抗凝、低分子右旋糖苷扩容为其主要的治疗手段。
The main treatment was low molecular weight heparin anticoagulation and low molecular weight dextran expansion.
版权声明:问题易所有作品(图文、音视频)均来源网络,版权归原创作者所有,与本站立场无关,如不慎侵犯了你的权益,请联系我们告知,我们将做删除处理!
